Abstract:
PURPOSE: A biomarker for confirming phenanthrene exposure is provided to monitor and determine phenanthrene pollution and to find a toxicity mechanism. CONSTITUTION: A biomarker for confirming phenanthrene contains a gene of which an expression is increased or decreased due to exposure to phenanthrene. A DNA microarray chip for confirming phenanthrene exposure contains oligotide having an entire or partial gene sequence or its complementary oligonuecleotide. A method for detecting the biomarker for confirming phenanthrene exposure comprises: a step of isolating RNA from a test person's somatic cells as an experimental group and normal somatic cells as a control group; a step of synthesizing cDNA of the experimental group and control group and labeling with different fluorescences; a step of hybridizing the labeled cDNA on a microarray chip; a step of analyzing DNA microarray chip; and a step of comparing expression level between control group and experimental group.
Abstract:
PURPOSE: A biomarker for detecting exposure to polycyclic aromatic hydrocarbons(PAHs) is provided to usefully monitor and determine contamination of PAHs and figure toxicity mechanism caused by the PAHs. CONSTITUTION: A biomarker for detecting exposure to polycyclic aromatic hydrocarbon(PAHs) contains a gene of which expression is decreased or increased by the exposure of the PAHs. A DNA microarray chip for detecting the exposure to the PAHs comprises oligonucleotide including entire or partial biomarker gene sequence and its complementary oligonucleotide. A method for detecting the exposure of the PAHs using the biomarker comprises: a step of isolating RNA from sample-derived human somatic cells as an experimental group and normal somatic cells as a control group; a step of synthesizing RNA to cDNA and labeling the experimental group and control group with different colors; a step of hybridizing the cDNA on the DNA microarray chip; a step of analyzing the DNA microarray chip; and a step of comparing the expression level between the experimental group and control group.
Abstract:
PURPOSE: A marker gene for screening drug causing pulmonary toxicity and a screening method using the same are provided to monitor and determine drug or chemical. CONSTITUTION: A marker gene for screening drug causing pulmonary toxicity contains gene of which expression by drug. The drug causing pulmonary toxicity is amiodarone and carbamazepine. A DNA microarray chip for detecting the drug contains oligonucleotide containing partial or whole marker gene sequence. A method for screening the drug causing pulmonary toxicity comprises: a step of treating test chemical to human bronchial epithelial cells; a step of isolating RNA from chemical-treated cells as an experimental group and untreated cells as a control group; a step of synthesizing RNA with the experimental group and control group; a step of labeling the cDNA with other fluorescence having other colors; a step of analyzing DNA microarray; and a step of comparing expression level.
Abstract:
PURPOSE: A biomarker for confirming exposure to chrysene is provided to monitor and determine chrysene contamination and study of toxic mechanism by the chrysene. CONSTITUTION: A method for detecting biomarker for confirming exposure of chrysene comprises: a step of isolating RNA from human somatic cell of sample as experimental group and somatic cell of control group; a step of synthesizing cDNA then hybridizing the experimental group and control group with different fluorescences; a step of hybridizing the cDNA on a DNA microarray chip; a step of analyzing the DNA microarray chip; and a step of comparing the expression level of biomarker between control group and experimental group.
Abstract:
A biomarker for identifying the exposure of benzophenone which is an endocrine disrupting chemical and identification method using the same are provided to monitor the benzophenone using the marker and determine harmfulness. A method for identifying a biomarker for identifying the exposure of benzophenone which is an endocrine disrupting chemical comprises: a step of isolating a RNA from a human somatic cell of test sample and a somatic cell as a control group; a step of amplifying cDNAs of experimental group and control group and labeling each different fluorescence; a step of hybridizing the cDNA with DNA microarray chip; and a step of comparing the expressions between the control group and experimental group.
Abstract:
A biomarker for identifying exposure of dichloromethane is provided to use reaction genes selected with DNA microarray chip, monitor dichloromethane and determine its harmfulness. A DNA microarray chip comprises oligonucleotide containing entire or a portion of biomarker for identifying dichloromethane exposure and its complementary strand. A method for identifying the exposure of dichloromethane comprises: a step of isolating RNAs from somatic cell of test sample as an experimental group and somatic cell of control group; a step of synthesizing the RNAs to cDNA and labeling with different fluorescence; a step of hybridizing cDNA on DNA microarray chip; a step of analyzing DNA microarray chip; and a step of comparing expression levels between control group and experimental group.
Abstract:
A biomarker is provided to confirm exposure of dibenzo· a, h·ªanthracene which is polycyclic aromatic hydrocarbon and to decrease or increase gene expression specifically by the dibenzo· a, h·ªanthracene. A method for confirming exposure of dibenzo· a, h·ªanthracene comprises the following steps of: processing an dibenzo· a, h·ªanthracene in a human somatic cell; separating RNA from the human somatic cell; noting the experimental group and a control group with other fluorescent materials respectively while synthesizing the RNA of the control group and the experimental group to cDNA; mixing a DNA microarray chip with the cDNA noted with the other fluorescent materials; analyzing the reacted DNA microarray chip; and confirming an expressed grade of the biomarker from analyzed data.
Abstract translation:提供了一种生物标志物来确认作为多环芳烃的二苯并··,confirm confirm confirm confirm and and and and and and to to to to to to to。。。。。。。。。。。。。。。。。 确认二苯并a,h-蒽的暴露方法包括以下步骤:在人体细胞中加工二苯并a,h-蒽; 从人体细胞分离RNA; 在将对照组和实验组的RNA合成cDNA的同时分别注射实验组和对照组; 将DNA微阵列芯片与其他荧光材料标记的cDNA混合; 分析反应的DNA微阵列芯片; 并从分析的数据确认生物标志物的表达等级。
Abstract:
본 발명은 휘발성 유기 화합물 검색용 바이오마커 및 이를 이용한 검색 방법에 관한 것으로, 구체적으로 휘발성 유기 화합물의 대표적인 화학물질인 벤젠, 톨루엔, 크실렌에 공통적으로 유전자 발현이 증가 또는 감소하는 바이오마커 및 이를 이용한 휘발성 유기 화합물의 검색 방법에 관한 것이다. 본 발명의 바이오마커는 DNA 마이크로어레이 칩을 통하여 선별된 반응 유전자들을 바이오마커로 이용하여 환경이나 실생활에서 휘발성 유기 화합물, 특히 유해성을 나타내는 휘발성 유기 화합물을 모니터링 및 판정하는데 유용하게 사용될 수 있으며, 휘발성 유기 화합물이 독성을 일으키는 작용 기작을 규명하는 도구로 이용될 수 있다. 휘발성 유기 화합물, 바이오마커, 마이크로어레이.
Abstract:
본 발명은 갑상선 과산화효소의 활성을 저해시키는 화학물질에 대한 노출 여부 확인용 DNA 마이크로어레이 칩 및 상기 마이크로어레이 칩을 이용하여 갑상선 과산화효소의 활성을 저해시키는 화학물질에 대한 노출 여부를 확인하는 방법에 관한 것으로, 구체적으로는 갑상선 호르몬 합성에 중요한 역할을 하는 갑상선 과산화효소를 활성화하는 화학물질인 2,2',4,4'-테트라히드록시벤조페논(2,2',4,4'-Tetrahydroxybenzophenone) 또는 빈클로졸린(vinclozolin)에 대한 노출 여부 확인용 바이오마커, 상기 바이오마커가 집적된 DNA 마이크로어레이 칩 및 이를 이용한 확인 방법에 관한 것으로 본 발명의 바이오마커는 DNA 마이크로어레이를 통하여 선별된 단백질 티로신 인산화효소(protein tyrosine phosphatase, non-receptor type 11)[유전자 등록번호(Genebank) NM_002834]를 바이오마커로 이용하여 환경 시료에서 갑상선 과산화효소를 활성화하는 화학물질의 오염을 모니터링 및 판정하는데 유용하게 사용될 수 있으며, 갑상선 과산화효소를 활성화하는 화학물질에 의해 유발되는 독성 작용 기작을 규명하는 도구로 이용될 수 있다.
Abstract:
본 발명은 인체 의약품 독성 유발 약물 탐색용 마커유전자 및 이를 이용한 탐색 방법에 관한 것으로, 더욱 상세하게는 폐독성, 최기형성, 신장독성, 심혈관독성 또는 돌연변이성를 유발하는 총 16종의 약물(메토트렉세이트, 니트로푸란토인, 아미오다론, 카르바마제핀, 발프론산, 탈리도마이드, 시스플란틴, 겐타마이신, 암포테리신, 푸리푸라아마이드, N-니트로-N-메틸우레아, 메틸메탄슬폰산, 4-니트로퀴놀린-N-옥사이드, 2-니트로플루오렌, 독소루비신 및 다우노루비신)에 의해 특이적으로 유전자 발현이 증가 또는 감소하는 마커유전자를 하나의 칩에 집적한 마이크로어레이칩, 상기 마이크로어레이칩을 포함하는 키트, 및 이를 이용한 인체 의약품 독성 유발 약물의 탐색 방법에 관한 것이다. 본 발명의 마커유전자를 포함하는 DNA 마이크로어레이 칩은 특정 약물에 특이적으로 반응하는 유전자들을 이용하여 인체 독성 유발 약물 탐색용 독소표적 어레이(Toxtarget Array)를 제작하여 인체 의약품 독성의 위험성을 지닌 약물 또는 화학물질을 모니터링 및 판정하는데 유용하게 사용될 수 있으며, 각 약물들의 독성 및 부작용을 일으키는 작용 기작을 규명하는 도구로 이용될 수 있다. 폐독성, 최기형성, 신장독성, 심혈관독성, 돌연변이성, 마커유전자, 마이크로어레이, 독소표적 어레이(Toxtarget Array).